None | 12 Mar 2010 | Africa Fighting Malaria
Quality Chemical Industries Limited of Uganda has been found to be operating in compliance with WHO Good Manufacturing Practices. This is an impressive start for local pharmaceutical manufacturing in Africa. However, there are still some big hurdles to clear: will they get WHO prequalification or SRA approval for a particular drug, after which they would be eligible for donor funding, and will they be able to produce at a low enough price to be competitive?
Jasson Urbach & Richard Tren | 03 Feb 2010 | Health Policy Unit
A consignment of fake anti-malaria drugs worth an estimated N10 million (approximately R500,000) was seized recently by the Nigerian National Agency of Food and Drugs Administration and Control (NAFDAC). Fake drugs do not cure patients' ailments. Usually they contain little
if any active ingredient and often contain chemicals that not only fail
to treat the underlying ailment but also cause direct harm to the
Richard Tren & Donald Roberts | 01 Jan 2010 | Environmental Health Perspectives
In his commentary "Global Status of DDT and Its Alternatives for Use in Vector Control to Prevent Disease," van den Berg (2009) raised concerns about the impact of DDT and its derivates on human health, in spite of the fact that DDT has been used widely for seven decades and no properly replicated and confirmed study has found any specific human health harm.
None | 10 Nov 2009 | Africa Fighting Malaria
Lawrence Cowper is a vector-borne disease specialist who has worked in public health in the United States and developing countries since 1951. He was Chief of the environmental health section for Guam between 1955 and 1959, after which he was appointed Chief Malaria Advisor to Nepal, where during the 1960s he built-up a highly successful malaria control program.
None | 02 Nov 2009 | Africa Fighting Malaria
On Thursday October 29th, AFM Director Richard Tren had an article published in South Africa's leading daily newspaper, Business Day, discussing new research from University of Pretoria scientists on DDT and human health.
Richard Tren | 29 Oct 2009 | Business Day (South Africa)
For years, fear and uncertainty, fuelled by politically driven and misleading information, undermined the fight against HIV/AIDS in SA. The result was the avoidable deaths of more than 300000 people. Now fear and uncertainty are being peddled again, this time against DDT use in malaria control.
None | 26 Oct 2009 | Africa Fighting Malaria
For six decades dichloro-diphenyl-trichloroethane (DDT) has been used successfully in indoor residual spraying programs to control malaria. During the many decades that DDT has been in use, thousands of tonnes of the chemical have been produced and used throughout the world with millions of people coming into direct contact with it in one way or another.
None | 05 Oct 2009 | Africa Fighting Malaria
In May 2009, the March of Washingtons distributed $30,000 to Soft Power Health for the purchase and distribution of antimalarial drugs in Uganda. Click here to watch a video update from Uganda.
Roger Bate | 01 Oct 2009 | American.com
The Indian government is touting a new survey showing a low percentage of drugs within the country are counterfeit. But the reality is that India still has a major problem with poor-quality drugs.
Roger Bate | 28 Sep 2009 | Wall Street Journal
Donating money to boost African access to essential drugs is a wonderful thing. But unless philanthropists insist on market principles in the continent's drug market, and until they apply necessary due diligence when cutting checks, their aid stands to be hijacked by governmental opportunism, incompetence and corruption.